eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-NUVL-Nuvalent Inc

Nuvalent Inc NUVL

‎$‎93.392.50(2.75%)(1D)
• Delayed prices by Nasdaq • in USD
Invest in Nuvalent Inc
Today
Create an eToro account to buy NUVL stock on a secure, user-friendly, multi-asset trading platform.
Buy Nuvalent Inc
Buy Nuvalent Inc
Nuvalent Inc NUVL
Buy NUVL
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Strong Buy
Price Target
125.40
Based on analysts who covered NUVL

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.
More about Nuvalent Inc
Nuvalent Inc - Class A is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. The company’s lead product candidates include an ROS1 inhibitor and an ALK inhibitor. Nuvalent is also developing a pipeline of other novel drug candidates targeting clinically proven kinase targets.

Nuvalent can be found within the healthcare sector, and it is committed to developing innovative therapies that can help patients with cancer achieve better outcomes. The company has a strong team of experienced scientists and drug developers.

Stay up to date on the share price of NUVL by adding it to your eToro watchlist.
VIEW MORE   

NUVL Stock Price Chart

‎14.79‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset positive trend

The Nuvalent Inc share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Nuvalent Inc share price today is ‎$‎93.39, reflecting a ‎2.75‎% change over the last 24 hours and ‎0.92‎% over the past week. The current market capitalization of NUVL is ‎$‎6.73B with an average volume in the last three months of 462147.97. The stock has a P/E ratio of -19.05 and a dividend yield of 0%. With the stock’s beta sitting at 1.3
NUVL Key Metrics
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
‎$‎6.73B
Day’s Range
i
Shows the high and low prices of the day.
‎$‎89.87 - ‎$‎95.7
52W Range
i
Shows the high and low prices of the last year.
‎$‎57.95 - ‎$‎112.42
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
462147.97
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-19.05
Revenue
i
The total income generated by this company’s goods and services last year.
‎$‎0
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
‎$‎0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
‎$‎93.39
EPS
i
A company’s total earnings divided by the number of shares it has issued.
‎$‎-4.9
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.3
What Is Nuvalent Inc?
Nuvalent Inc - Class A is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. The company’s lead product candidates include an ROS1 inhibitor and an ALK inhibitor. Nuvalent is also developing a pipeline of other novel drug candidates targeting clinically proven kinase targets.

Nuvalent can be found within the healthcare sector, and it is committed to developing innovative therapies that can help patients with cancer achieve better outcomes. The company has a strong team of experienced scientists and drug developers.

Stay up to date on the share price of NUVL by adding it to your eToro watchlist.
Get Started

How can I buy Nuvalent Inc stocks?

To purchase Nuvalent Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Nuvalent Inc (NUVL) page and place an order to buy Nuvalent Inc.
Buy NUVL
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Nuvalent Inc
Invest in Nuvalent Inc
Today
Create an eToro account to buy NUVL stock on a secure, user-friendly, multi-asset trading platform.
Get Started

FAQ

The current price of NUVL is ‎$‎93.39.
The average price target for Nuvalent Inc is ‎$‎125.40. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Nuvalent Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Nuvalent Inc is ‎$‎6.73B
Based on 6 analysts offering recommendations for NUVL in the last 3 months, the overall consensus is Strong Buy.
Daily Movers
Explore the biggest stocks movers on the market.
English (UK)Check icon
Deutsch
Français
Polski
Português
Dansk
Suomi
Español
Русский
العربية
Nederlands
Svenska
Română
Italiano
中文
繁體中文
Norsk
Čeština
Tiếng Việt
Scroll to top